
Market Musings - March 10, 2018
We continue our blog series: Market Musings, Volume 2, Edition 13, giving our (hopefully not too random) thoughts on recent goings-on in the markets. Today, we present "Instant Analysis - Allergan 2017 Form 10-K Filing". On February 16, 2018, Allergan Plc (AGN) filed with the SEC its 2017 Form 10-K filing. This blog will perform an instant analysis the risk factors section of the document (each excerpt is redlined against the respective text from Allergan's 2016 Form 10-K fil


Market Musings - March 2, 2018
We continue our blog series: Market Musings, Volume 2, Edition 12, giving our (hopefully not too random) thoughts on recent goings-on in the markets. Today, we present "Instant Analysis - Tesla 2017 Form 10-K Filing". Last Friday Tesla (TSLA) filed its 2017 Form 10-K filing. This blog will perform an instant analysis the risk factors section of the document (each excerpt is redlined against the respective text from the 2016 10-K). EXCERPT 1 Instant Analysis: Tesla admits that